FTC's Merger Concerns Remain Despite Amgen’s ‘Bare Commitment’ Not To Bundle Horizon Drugs

 
• By Brenda Sandburg
  
FTC building
The FTC wants a preliminary injunction to block Amgen's acquisition of Horizon. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet